Coverage
-
July 23, 2018
Former high-flying Silicon Valley blood-testing company Theranos Inc., whose founder was indicted last month for criminal fraud, has settled a proposed class action brought by a group of indirect investors who claimed they were harmed by false and misleading statements made by the company, according to documents filed Friday in California federal court.
13 other articles on this case.
View all »